Latham Adds Prominent Life Sciences Patent Litigator

Adam Perlman joins the firm’s market-leading IP trial team in Washington, D.C.

January 21, 2020

Latham & Watkins LLP1 is pleased to announce that Adam Perlman has joined the firm’s Washington, D.C. office as a partner in the Litigation & Trial Department and Intellectual Property Litigation Practice. Perlman is a first-chair patent trial lawyer who focuses on Hatch-Waxman trials and Federal Circuit appeals for brand-name pharmaceutical manufacturers.

Perlman has served as lead counsel in major patent litigations in district courts around the country, and as lead appellate counsel before the US Court of Appeals for the Federal Circuit. His practice involves a wide range of technologies, including pharmaceuticals, biotechnology, and medical devices, as well as computers and financial services. Perlman has significant experience litigating life science inter partes review proceedings before the US Patent and Trademark Office.

David Callahan, Global Chair of the firm’s Intellectual Property Litigation Practice, said: “Adam is a fantastic addition to the IP Litigation Practice who is known for successfully representing some of the world’s leading drug innovators in complex ANDA litigation. His experience complements Latham’s formidable courtroom reputation and adds further breadth to our life sciences platform. More broadly, Adam’s arrival follows the additions of former General Counsel at the US Copyright Office Sy Damle, IP trial lawyer Tara Elliott, and International Trade Commission litigator Jamie Underwood in Washington, D.C., whose work reflects the caliber of our Intellectual Property Litigation Practice across industries.”

John Manthei, Global Co-Chair of Latham’s Life Sciences Industry Group, said: “At Latham, we are focused on delivering top-notch counseling and advocacy to our healthcare and life sciences clients, across a range of practice areas, whether litigation, transactional, or regulatory. Adam’s addition will further fortify our ability to offer full-service, best-in-class representation to our innovative pharmaceutical and biotech clients. We are thrilled to have him on board.”    

Michael Egge, Office Managing Partner of Latham in Washington, D.C., said: “We are extremely pleased that Adam will be joining Latham’s seasoned team of trial lawyers in Washington, D.C. Not only will he further bolster our patent litigation capabilities in the life sciences industry, but clients will certainly value his thoughtful guidance, experience, and dedication to client service.”

“I’m delighted to be joining Latham, a global firm with seamless intellectual property capabilities, a collaborative approach, and an emphasis on trial readiness,” said Perlman. “I’ve been impressed by the group’s steady growth into the powerhouse that it is today, and I look forward to contributing to its further success.”

Perlman joins Latham from Williams & Connolly LLP in Washington, D.C. He earned his BA magna cum laude from Tufts University in 1994 and graduated summa cum laude, Order of the Coif from the University of Pennsylvania Law School in 1997. Following law school, he clerked for Judge Garbis in the US District Court for the District of Maryland.

About Latham & Watkins (

Latham & Watkins delivers innovative solutions to complex legal and business challenges around the world. From a global platform, our lawyers advise clients on market-shaping transactions, high-stakes litigation and trials, and sophisticated regulatory matters. Latham is one of the world’s largest providers of pro bono services, steadfastly supports initiatives designed to advance diversity within the firm and the legal profession, and is committed to exploring and promoting environmental sustainability.

Notes to Editors

1Latham & Watkins operates worldwide as a limited liability partnership organized under the laws of the State of Delaware (USA) with affiliated limited liability partnerships conducting the practice in France, Hong Kong, Italy, Singapore, and the United Kingdom and as an affiliated partnership conducting the practice in Japan. Latham & Watkins operates in South Korea as a Foreign Legal Consultant Office. Latham & Watkins works in cooperation with the Law Office of Salman M. Al-Sudairi in the Kingdom of Saudi Arabia.


David Callahan, Global Chair of the Intellectual Property Litigation Practice, +1.312.876.7694

John Manthei, Global Co-Chair of the Life Sciences Industry Group, +1.202.637.2211

Michael Egge, Washington, D.C. Office Managing Partner: +1.202.637.2285

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.